Development of spin-labeled probes for adenosine receptors

J Med Chem. 2005 Mar 24;48(6):2108-14. doi: 10.1021/jm049513x.

Abstract

Functionalized xanthine derivatives bearing a nitroxide moiety at the 3- or 8-position were synthesized as electron paramagnetic resonance (EPR) probes. The 8-cyclopentyl-1-propylxanthine derivative 4, spin-labeled at N3 by substitution with a nitroxide-bearing dihydropyrrole moiety, was a potent and selective A(1) adenosine receptor antagonist (K(i) for A(1) 5.5 nM, 1600-fold selectivity vs A(2A), >200-fold vs A(2B), and 310-fold vs A(3) adenosine receptors). 8-(1-Oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)-1,3-dipropylxanthine 10 (K(i) for A(1) 8.2 nM) was similarly potent and selective, while 8-(1-oxyl-2,2,6,6-tetramethylpiperidin-4-yl)-1,3-dipropylxanthine 11 (K(i) for A(1) 160 nM) exhibited significantly lower affinity for A(1) adenosine receptors. 8-[4-(((1-Oxyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)-2-oxoethoxy)phenyl]-1-propylxanthine14, a 3-unsubstituted xanthine derivative, was found to be a potent A(2B) adenosine receptor antagonist (K(i) for A(2B) 48 nM) but also exhibited high affinity for A(1) receptors (K(i) for A(1) 15.7 nM). An X-ray structure of compound 10 was obtained, confirming the proposed structure. The novel spin-labeled A(1)-selective or A(1)/A(2B)-nonselective adenosine receptor antagonists may become useful probes for biophysicochemical investigations of adenosine receptors in their membrane environment.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine A1 Receptor Antagonists
  • Adenosine A2 Receptor Antagonists
  • Animals
  • Binding, Competitive
  • Brain / drug effects
  • Brain / metabolism
  • Cell Line
  • Cricetinae
  • Cricetulus
  • Crystallography, X-Ray
  • Cyclic N-Oxides / chemical synthesis*
  • Cyclic N-Oxides / chemistry
  • Cyclic N-Oxides / pharmacology
  • Cyclopentanes / chemical synthesis*
  • Cyclopentanes / chemistry
  • Cyclopentanes / pharmacology
  • Humans
  • In Vitro Techniques
  • Ligands
  • Molecular Structure
  • Purinergic P1 Receptor Antagonists
  • Radioligand Assay
  • Rats
  • Receptor, Adenosine A1 / metabolism
  • Receptor, Adenosine A2B / metabolism
  • Receptors, Purinergic P1 / metabolism*
  • Spin Labels / chemical synthesis*
  • Structure-Activity Relationship
  • Xanthines / chemical synthesis*
  • Xanthines / chemistry
  • Xanthines / pharmacology

Substances

  • 8-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-yl)-1,3-dipropylxanthine
  • 8-(4-(((1-oxyl-2,2,6,6-tetramethylpiperidin-4-yl)amino)-2-oxoethoxy)phenyl)-1-propylxanthine
  • 8-cyclopentyl-3-(1-oxyl-2,2,5,5-tetramethyl-2,5-dihydro-1H-pyrrol-3-ylmethyl)-1-propylxanthine
  • Adenosine A1 Receptor Antagonists
  • Adenosine A2 Receptor Antagonists
  • Cyclic N-Oxides
  • Cyclopentanes
  • Ligands
  • Purinergic P1 Receptor Antagonists
  • Receptor, Adenosine A1
  • Receptor, Adenosine A2B
  • Receptors, Purinergic P1
  • Spin Labels
  • Xanthines